Positive drug screen or refusal to provide a urine sample · drug‐using offenders with co‐occurring mental health problems
1 finding from 1 review
Drug dependence · drug‐using offenders with co‐occurring mental health problems
1 finding from 1 review
Drug use · female offenders
It is very uncertain whether community‐based buprenorphine changes end of treatment drug use compared with placebo (very low certainty).
1 finding from 1 review
Retention [ · concurrent problem alcohol and illicit drug users
Motivational interviewing (MI) showed no clear difference in retention ‐ end of treatment compared with treatment (low certainty).
2 findings from 1 review
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
It is very uncertain whether PFMT added to bladder training changes number of women requiring further treatment such as surgery, drugs,… compared with bladder training alone (very low certainty).
1 finding from 1 review
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring further treatment such as surgery, drugs, mechanical devices (relapse) ‐ not reported · women with urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary embolism · acute ischaemic stroke
It is very uncertain whether antiplatelet drug changes pulmonary embolism during treatment period compared with control (very low certainty).
1 finding from 1 review
Recurrent ischaemic or unknown stroke during treatment period · acute ischaemic stroke
It is very uncertain whether antiplatelet drug changes recurrent ischaemic/unknown stroke during treatment period compared with control (very low certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage during treatment period · acute ischaemic stroke
It is very uncertain whether antiplatelet drug changes symptomatic intracranial haemorrhage during treatment period compared with control (very low certainty).
1 finding from 1 review
Major extracranial haemorrhage during treatment period · acute ischaemic stroke
It is very uncertain whether antiplatelet drug changes major extracranial haemorrhage during treatment period compared with control (very low certainty).
1 finding from 1 review
Secondary outcome: acceptability of treatment · patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether CHOLINERGIC DRUGS changes acceptability of treatment: Leaving the study early compared with PLACEBO (very low certainty).
1 finding from 1 review
Seizure recurrence at 5 years after randomisation · patients with first unprovoked seizure
Immediate treatment leads to lower seizure recurrence at 5 years after randomisation compared with controls (high certainty).
1 finding from 1 review
Five year immediate remission after randomisation · patients with first unprovoked seizure
Immediate treatment leads to higher five‐year immediate remission after randomisation compared with controls (high certainty).
1 finding from 1 review
Five year remission at any time after randomisation · patients with first unprovoked seizure
Immediate treatment showed no clear difference in five‐year remission at any time after randomisation compared with controls (high certainty).
1 finding from 1 review